Ivana K. Kim,
MD
Massachusetts Eye and Ear
Director, Retina Clinical Research
Harvard Medical School
Co-director, AMD Center of Excellence
Co-director, Ocular Oncology Center of Excellence
ivana_kim@meei.harvard.edu
For investigator inquiries only
About My Research
Centers of Excellence/Institutes
- AMD Center of Excellence
- Diabetic Eye Disease Center of Excellence
- Mobility Enhancement and Vision Rehabilitation Center of Excellence
- Ocular Oncology Center of Excellence
- Ocular Regenerative Medicine Institute
Research Programs/Laboratories
- Ines and Frederick Yeatts Retina Research Laboratory
- Harvard Retinal Imaging Laboratory
- JW Miller AMD Research Group
- Harvard Retinal Metabolomics Program
Biography
Dr. Kim is the Evangelos S. Gragoudas Distinguished Scholar in Retina at Mass Eye and Ear. In addition to serving as Co-Director of the Harvard Ophthamoogy AMD and Ocular Oncology Centers of Excellence, she co-directs the Ocular Melanoma Center at Mass Eye and Ear.
Her research focuses on the medical and surgical treatment of patients with vitreoretinal diseases. Additionally, she conducts clinical and translational research directed toward the development of new therapies for AMD and ocular melanoma. Together with Drs. Margaret DeAngelis and Joan Miller, she has described novel associations of genes such as RORA, ROB01, and CYP24A 1 with AMD that may highlight important pathways in AMD pathogenesis. Dr. Kim has also initiated and participates in various clinical trials involving new therapeutic approaches for uveal melanoma. Additionally, she has an ongoing collaboration with investigators at Massachusetts General Hospital and the Broad Institute evaluating circulating DNA as a biomarker for uveal melanoma progression.
Research Projects
Investigation of circulating biomarkers in uveal melanoma
Investigation of new therapies for improving visual outcomes in patients with uveal melanoma
Education
1992: BS, Biological Sciences, Honors and Distinction, Stanford University
1997: MD, Harvard Medical School
Postgraduate Training
1998: Internship, Medicine, Massachusetts General Hospital
2001: Residency, Ophthalmology, Harvard Medical School
2003: Fellowship, Retina, Massachusetts Eye and Ear
2003: Chief Retina Fellow, Massachusetts Eye and Ear
Academic Appointments
2012-present: Associate Professor of Ophthalmology, Harvard Medical School
2007-2012: Assistant Professor of Ophthalmology, Harvard Medical School
2003-2007: Instructor in Ophthalmology, Harvard Medical School
Professional Memberships
American Ophthalmological Society
American Academy of Ophthalmology
American Society of Retina Specialists
Club Jules Gonin
Macula Society
Retina Society
Honors
Research to Prevent Blindness Physician Scientist Award
Evangelos S. Gragoudas Distinguished Retina Scholar
AAO Achievement Award
ASRS Honor Award
Publications powered by Harvard Catalyst Profiles
- Detection of Copy-Number Variation in Circulating Cell-Free DNA in Patients With Uveal Melanoma. JCO Precis Oncol. 2024 Jan; 8:e2300368.
- Patterns of Gene Expression, Splicing, and Allele-Specific Expression Vary among Macular Tissues and Clinical Stages of Age-Related Macular Degeneration. Cells. 2023 11 21; 12(23).
- DeMixSC: a deconvolution framework that uses single-cell sequencing plus a small benchmark dataset for improved analysis of cell-type ratios in complex tissue samples. bioRxiv. 2023 Nov 11.
- Outcomes after Proton Beam Irradiation in Patients with Choroidal Melanoma Eligible for Investigational AU-011 Treatment. Ocul Oncol Pathol. 2023 Dec; 9(5-6):152-157.
- Survival of patients with recurrent uveal melanoma after treatment with radiation therapy. Br J Ophthalmol. 2023 Jul 03.
- Plasma Metabolites Associated with OCT Features of Age-Related Macular Degeneration. Ophthalmol Sci. 2024 Jan-Feb; 4(1):100357.
- Integrating genetics and metabolomics from multi-ethnic and multi-fluid data reveals putative mechanisms for age-related macular degeneration. Cell Rep Med. 2023 07 18; 4(7):101085.
- Growth rate of indeterminate choroidal lesions prior to melanoma diagnosis. Graefes Arch Clin Exp Ophthalmol. 2023 Dec; 261(12):3635-3641.
- A systems biology approach uncovers novel disease mechanisms in age-related macular degeneration. Cell Genom. 2023 Jun 14; 3(6):100302.
- A multi-omics atlas of the human retina at single-cell resolution. Cell Genom. 2023 Jun 14; 3(6):100298.
- In Reply to Elmali and Yazici. Int J Radiat Oncol Biol Phys. 2023 Mar 01; 115(3):810-811.
- The NLRP3 inflammasome - interleukin 1ß axis in uveal melanoma. FEBS Open Bio. 2023 03; 13(3):545-555.
- Expression and subcellular localization of USH1C/harmonin in human retina provides insights into pathomechanisms and therapy. Hum Mol Genet. 2023 01 13; 32(3):431-449.
- Low-dose proton radiotherapy for pediatric choroidal hemangioma: A case series. Pediatr Blood Cancer. 2022 12; 69(12):e29925.
- A Systematic Comparison of Dose Distributions Delivered in 125I Plaque Brachytherapy and Proton Radiation Therapy for Ocular Melanoma. Int J Radiat Oncol Biol Phys. 2023 02 01; 115(2):501-510.
- A Comparison of Treatment Outcomes after Standard Dose (70 Gy) versus Reduced Dose (50 Gy) Proton Radiation in Patients with Uveal Melanoma. Ophthalmol Retina. 2022 11; 6(11):1089-1097.
- Primary vitreoretinal involvement and immunopositivity for BRAFV600E help distinguish metastatic from primary intraocular melanoma: a detailed histopathologic study of metastatic cutaneous melanoma to the eye. Histopathology. 2022 Jun; 80(7):1061-1070.
- AMD Genomics: Non-Coding RNAs as Biomarkers and Therapeutic Targets. J Clin Med. 2022 Mar 09; 11(6).
- Urinary Mass Spectrometry Profiles in Age-Related Macular Degeneration. J Clin Med. 2022 Feb 11; 11(4).
- Primary central nervous system lymphoma: Inter-compartmental progression. EJHaem. 2022 May; 3(2):362-370.
- Treatment of Aggressive Retinal Astrocytic Hamartoma with Oral Mechanistic Target of Rapamycin Inhibition. Ophthalmol Retina. 2022 05; 6(5):411-420.
- Plasma Metabolomic Profiles Associated with Three-Year Progression of Age-Related Macular Degeneration. Metabolites. 2022 Jan 01; 12(1).
- BASELINE PREDICTORS ASSOCIATED WITH 3-YEAR CHANGES IN DARK ADAPTATION IN AGE-RELATED MACULAR DEGENERATION. Retina. 2021 Oct 01; 41(10):2098-2105.
- Implication of N-Methyl-d-Aspartate Receptor in Homocysteine-Induced Age-Related Macular Degeneration. Int J Mol Sci. 2021 Aug 28; 22(17).
- Area under the dark adaptation curve as a reliable alternate measure of dark adaptation response. Br J Ophthalmol. 2022 10; 106(10):1450-1456.
- Targeting the YAP/TAZ Pathway in Uveal and Conjunctival Melanoma With Verteporfin. Invest Ophthalmol Vis Sci. 2021 04 01; 62(4):3.
- Association of Human Plasma Metabolomics with Delayed Dark Adaptation in Age-Related Macular Degeneration. Metabolites. 2021 Mar 21; 11(3).
- Genomic-Metabolomic Associations Support the Role of LIPC and Glycerophospholipids in Age-Related Macular Degeneration. Ophthalmol Sci. 2021 Mar; 1(1).
- Reply. Ophthalmol Retina. 2021 03; 5(3):e4.
- Current Management of Age-Related Macular Degeneration. Adv Exp Med Biol. 2021; 1256:295-314.
- Proton beam irradiation of uveal melanoma involving the iris, ciliary body and anterior choroid without surgical localisation (light field). Br J Ophthalmol. 2022 04; 106(4):518-521.
- Risk of Inflammation, Retinal Vasculitis, and Retinal Occlusion-Related Events with Brolucizumab: Post Hoc Review of HAWK and HARRIER. Ophthalmology. 2021 07; 128(7):1050-1059.
- Higher Intake of Polyunsaturated Fatty Acid and Monounsaturated Fatty Acid is Inversely Associated With AMD. Invest Ophthalmol Vis Sci. 2020 02 07; 61(2):20.
- Intravitreous Cutaneous Metastatic Melanoma in the Era of Checkpoint Inhibition: Unmasking and Masquerading. Ophthalmology. 2020 02; 127(2):240-248.
- Diagnostic and Therapeutic Challenges. Retina. 2019 08; 39(8):1632-1634.
- Human Plasma Metabolomics in Age-Related Macular Degeneration: Meta-Analysis of Two Cohorts. Metabolites. 2019 Jul 02; 9(7).
- Characterization of Epiretinal Proliferation in Full-Thickness Macular Holes and Effects on Surgical Outcomes. Ophthalmol Retina. 2019 08; 3(8):694-702.
- Conservative management of suspicious melanocytic lesions of the iris. Graefes Arch Clin Exp Ophthalmol. 2019 Jun; 257(6):1319-1324.
- Urine Nuclear Magnetic Resonance (NMR) Metabolomics in Age-Related Macular Degeneration. J Proteome Res. 2019 03 01; 18(3):1278-1288.
- Microperimetry in age-related macular degeneration: association with macular morphology assessed by optical coherence tomography. Br J Ophthalmol. 2019 12; 103(12):1769-1776.
- Choroidal thickness and vascular density in macular telangiectasia type 2 using enface swept-source optical coherence tomography. Br J Ophthalmol. 2019 11; 103(11):1584-1589.
- Survival Rates in Patients After Treatment for Metastasis From Uveal Melanoma. JAMA Ophthalmol. 2018 09 01; 136(9):981-986.
- Reply. Ophthalmology. 2018 07; 125(7):e46-e47.
- HEALTH CONDITIONS LINKED TO AGE-RELATED MACULAR DEGENERATION ASSOCIATED WITH DARK ADAPTATION. Retina. 2018 Jun; 38(6):1145-1155.
- Peripheral Changes Associated With Delayed Dark Adaptation in Age-related Macular Degeneration. Am J Ophthalmol. 2018 06; 190:113-124.
- Evaluation of choroidal lesions with swept-source optical coherence tomography. Br J Ophthalmol. 2019 01; 103(1):88-93.
- Genetic Risk Factors for Radiation Vasculopathy. Invest Ophthalmol Vis Sci. 2018 03 01; 59(3):1547-1553.
- Hemorrhagic choroidal melanoma. Am J Ophthalmol Case Rep. 2018 Jun; 10:105-107.
- CHOROIDAL THICKNESS IN DIABETIC RETINOPATHY ASSESSED WITH SWEPT-SOURCE OPTICAL COHERENCE TOMOGRAPHY. Retina. 2018 Jan; 38(1):173-182.
- Novel grid combined with peripheral distortion correction for ultra-widefield image grading of age-related macular degeneration. Clin Ophthalmol. 2017; 11:1967-1974.
- Long-term Outcomes After Proton Beam Irradiation in Patients With Large Choroidal Melanomas. JAMA Ophthalmol. 2017 11 01; 135(11):1191-1196.
- Diabetic Choroidopathy: Choroidal Vascular Density and Volume in Diabetic Retinopathy With Swept-Source Optical Coherence Tomography. Am J Ophthalmol. 2017 Dec; 184:75-83.
- Genetics of age-related macular degeneration (AMD). Hum Mol Genet. 2017 10 01; 26(R2):R246.
- Human Plasma Metabolomics Study across All Stages of Age-Related Macular Degeneration Identifies Potential Lipid Biomarkers. Ophthalmology. 2018 02; 125(2):245-254.
- Genetics of age-related macular degeneration (AMD). Hum Mol Genet. 2017 08 01; 26(R1):R45-R50.
- Systematic genomic and translational efficiency studies of uveal melanoma. PLoS One. 2017; 12(6):e0178189.
- Choroidal Changes Associated With Subretinal Drusenoid Deposits in Age-related Macular Degeneration Using Swept-source Optical Coherence Tomography. Am J Ophthalmol. 2017 Aug; 180:55-63.
- Human plasma metabolomics in age-related macular degeneration (AMD) using nuclear magnetic resonance spectroscopy. PLoS One. 2017; 12(5):e0177749.
- Structural Changes Associated with Delayed Dark Adaptation in Age-Related Macular Degeneration. Ophthalmology. 2017 09; 124(9):1340-1352.
- Automated Brightness and Contrast Adjustment of Color Fundus Photographs for the Grading of Age-Related Macular Degeneration. Transl Vis Sci Technol. 2017 Mar; 6(2):3.
- Severe corneal ulcer with progression to endophthalmitis and high-grade bacteremia. Am J Ophthalmol Case Rep. 2017 Jun; 6:30-32.
- Treatment of Refractory Acute Retinal Necrosis with Intravenous Foscarnet or Cidofovir. Ocul Immunol Inflamm. 2018; 26(2):199-203.
- Characteristics and Outcomes of Simultaneous Bilateral Rhegmatogenous Retinal Detachments. Ophthalmic Surg Lasers Imaging Retina. 2016 09 01; 47(9):840-5.
- Ranibizumab for the Prevention of Radiation Complications in Patients Treated With Proton Beam Irradiation for Choroidal Melanoma. Trans Am Ophthalmol Soc. 2016 Aug; 114:T2.
- Long-term Follow-up and Outcomes in Traumatic Macular Holes. Am J Ophthalmol. 2016 06; 166:206-207.
- A New Variant of Polypoidal Choroidal Vasculopathy With Annular Pigmentary Changes in Haitian Males. Ophthalmic Surg Lasers Imaging Retina. 2016 Apr 01; 47(4):381-6.
- Second Primary Neoplasms in Patients With Uveal Melanoma: A SEER Database Analysis. Am J Ophthalmol. 2016 05; 165:54-64.
- Regression of Some High-risk Features of Age-related Macular Degeneration (AMD) in Patients Receiving Intensive Statin Treatment. EBioMedicine. 2016 Mar; 5:198-203.
- Long-term Risk of Melanoma-Related Mortality After Uveal Melanoma--Reply. JAMA Ophthalmol. 2016 Feb; 134(2):239-40.
- Unilateral Eye Findings: A Rare Herald of Acute Leukemia. Ocul Oncol Pathol. 2016 Apr; 2(3):166-70.
- A large genome-wide association study of age-related macular degeneration highlights contributions of rare and common variants. Nat Genet. 2016 Feb; 48(2):134-43.
- Visual Outcomes after Proton Beam Irradiation for Choroidal Melanomas Involving the Fovea. Ophthalmology. 2016 Feb; 123(2):369-377.
- Long-term Follow-up and Outcomes in Traumatic Macular Holes. Am J Ophthalmol. 2015 Dec; 160(6):1255-1258.e1.
- Clinical Characteristics of Uveal Melanoma in Patients With Germline BAP1 Mutations. JAMA Ophthalmol. 2015 Aug; 133(8):881-7.
- Ancestry of the Timorese: age-related macular degeneration associated genotype and allele sharing among human populations from throughout the world. Front Genet. 2015; 6:238.
- Long-term Risk of Melanoma-Related Mortality for Patients With Uveal Melanoma Treated With Proton Beam Therapy. JAMA Ophthalmol. 2015 Jul; 133(7):792-6.
- Age-Related Macular Degeneration: Advances in Management and Diagnosis. J Clin Med. 2015 Feb 12; 4(2):343-59.
- Ultrasonographic biomicroscopy in lens-induced glaucoma. JAMA Ophthalmol. 2015 Jan; 133(1):112.
- Immunohistochemical investigations of adult intraocular medulloepitheliomas. Clin Exp Ophthalmol. 2015 May-Jun; 43(4):379-85.
- Outcomes of proton therapy for the treatment of uveal metastases. Int J Radiat Oncol Biol Phys. 2014 Dec 01; 90(5):1044-50.
- Clinical characteristics and current treatment of age-related macular degeneration. Cold Spring Harb Perspect Med. 2014 Oct 03; 5(1):a017178.
- Rare and common variants in extracellular matrix gene Fibrillin 2 (FBN2) are associated with macular degeneration. Hum Mol Genet. 2014 Nov 01; 23(21):5827-37.
- Author response: additional considerations in the utility of dark adaptometry for the diagnosis of age-related macular degeneration. Invest Ophthalmol Vis Sci. 2014 May 19; 55(5):3149.
- Proton beam irradiation for non-AMD CNV: 2-year results of a randomised clinical trial. Br J Ophthalmol. 2014 Sep; 98(9):1212-7.
- Aggressive skull base metastasis from uveal melanoma: a clinicopathologic study. Eur J Ophthalmol. 2014 Sep-Oct; 24(5):811-3.
- FLT1 genetic variation predisposes to neovascular AMD in ethnically diverse populations and alters systemic FLT1 expression. Invest Ophthalmol Vis Sci. 2014 May 08; 55(6):3543-54.
- Author reply: To PMID 23972322. Ophthalmology. 2014 Aug; 121(8):e39.
- Diagnostic sensitivity and specificity of dark adaptometry for detection of age-related macular degeneration. Invest Ophthalmol Vis Sci. 2014 Mar 10; 55(3):1427-31.
- Identification of a rare coding variant in complement 3 associated with age-related macular degeneration. Nat Genet. 2013 Nov; 45(11):1375-9.
- A review of advanced genetic testing for clinical prognostication in uveal melanoma. Semin Ophthalmol. 2013 Sep-Nov; 28(5-6):361-71.
- CFH and ARMS2 genetic polymorphisms predict response to antioxidants and zinc in patients with age-related macular degeneration. Ophthalmology. 2013 Nov; 120(11):2317-23.
- Conversion to aflibercept for chronic refractory or recurrent neovascular age-related macular degeneration. Am J Ophthalmol. 2013 Jul; 156(1):29-35.e2.
- Age-related macular degeneration-associated silent polymorphisms in HtrA1 impair its ability to antagonize insulin-like growth factor 1. Mol Cell Biol. 2013 May; 33(10):1976-90.
- Seven new loci associated with age-related macular degeneration. Nat Genet. 2013 Apr; 45(4):433-9, 439e1-2.
- Intravitreal injections at the Massachusetts Eye and Ear Infirmary: analysis of treatment indications and postinjection endophthalmitis rates. Br J Ophthalmol. 2013 Apr; 97(4):460-5.
- Pharmacogenetics for genes associated with age-related macular degeneration in the Comparison of AMD Treatments Trials (CATT). Ophthalmology. 2013 Mar; 120(3):593-599.
- Choroiditis and choroidal neovascularization in acute disseminated encephalomyelitis. Retin Cases Brief Rep. 2013; 7(1):89-90.
- Epidemiology and management of uveal melanoma. Hematol Oncol Clin North Am. 2012 Dec; 26(6):1169-84.
- High throughput mass spectrometry-based mutation profiling of primary uveal melanoma. Invest Ophthalmol Vis Sci. 2012 Oct 09; 53(11):6991-6.
- Germline BAP1 inactivation is preferentially associated with metastatic ocular melanoma and cutaneous-ocular melanoma families. PLoS One. 2012; 7(4):e35295.
- Pseudophakic cystoid macular edema. Curr Opin Ophthalmol. 2012 Jan; 23(1):26-32.
- Anti-vascular endothelial growth factor monotherapy versus combination treatment with photodynamic therapy for subfoveal choroidal neovascularization secondary to causes other than age-related macular degeneration. Retina. 2011 Nov; 31(10):2078-83.
- Influence of ROBO1 and RORA on risk of age-related macular degeneration reveals genetically distinct phenotypes in disease pathophysiology. PLoS One. 2011; 6(10):e25775.
- Systems biology-based analysis implicates a novel role for vitamin D metabolism in the pathogenesis of age-related macular degeneration. Hum Genomics. 2011 Oct; 5(6):538-68.
- Proton irradiation for peripapillary and parapapillary melanomas. Arch Ophthalmol. 2011 Sep; 129(9):1127-30.
- Identifying subtypes of patients with neovascular age-related macular degeneration by genotypic and cardiovascular risk characteristics. BMC Med Genet. 2011 Jun 17; 12:83.
- In vivo evaluation of laser-induced choroidal neovascularization using spectral-domain optical coherence tomography. Invest Ophthalmol Vis Sci. 2011 Jun 01; 52(6):3880-7.
- Genetics of age-related macular degeneration: current concepts, future directions. Semin Ophthalmol. 2011 May; 26(3):77-93.
- Utilizing targeted gene therapy with nanoparticles binding alpha v beta 3 for imaging and treating choroidal neovascularization. PLoS One. 2011 Apr 29; 6(4):e18864.
- Inhibition of choroidal neovascularization in a nonhuman primate model by intravitreal administration of an AAV2 vector expressing a novel anti-VEGF molecule. Mol Ther. 2011 Feb; 19(2):260-5.
- Comparison of 20-gauge transconjunctival sutureless vitrectomy with conventional vitrectomy. Retina. 2010 Oct; 30(9):1496-504.
- Posterior uveal melanoma in young patients treated with proton beam therapy. Retina. 2010 Sep; 30(8):1267-71.
- Ranibizumab for choroidal neovascularization secondary to causes other than age-related macular degeneration: a phase I clinical trial. Ophthalmology. 2011 Jan; 118(1):111-8.
- Mortality after diagnosis of small melanocytic lesions of the choroid. Arch Ophthalmol. 2010 Aug; 128(8):996-1000.
- Survival in patients with presymptomatic diagnosis of metastatic uveal melanoma. Arch Ophthalmol. 2010 Jul; 128(7):871-5.
- Genetic variants near TIMP3 and high-density lipoprotein-associated loci influence susceptibility to age-related macular degeneration. Proc Natl Acad Sci U S A. 2010 Apr 20; 107(16):7401-6.
- Natural history of radiation papillopathy after proton beam irradiation of parapapillary melanoma. Ophthalmology. 2010 Aug; 117(8):1617-22.
- Proton beam irradiation using a light-field technique for the treatment of choroidal hemangiomas. Ophthalmologica. 2010; 224(4):209-16.
- Comprehensive analysis of complement factor H and LOC387715/ARMS2/HTRA1 variants with respect to phenotype in advanced age-related macular degeneration. Am J Ophthalmol. 2009 Dec; 148(6):869-74.
- Convergence of linkage, gene expression and association data demonstrates the influence of the RAR-related orphan receptor alpha (RORA) gene on neovascular AMD: a systems biology based approach. Vision Res. 2010 Mar 31; 50(7):698-715.
- A case of carotid aneurysm in familial retinal arterial tortuosity. Korean J Ophthalmol. 2009 Mar; 23(1):57-8.
- Radiation therapy for neovascular age-related macular degeneration revisited. Br J Ophthalmol. 2009 Mar; 93(3):279-80.
- Ocular melanocytoma. Int Ophthalmol Clin. 2009; 49(1):165-75.
- Comprehensive analysis of CRP, CFH Y402H and environmental risk factors on risk of neovascular age-related macular degeneration. Mol Vis. 2008 Aug 11; 14:1487-95.
- The NEI/NCBI dbGAP database: genotypes and haplotypes that may specifically predispose to risk of neovascular age-related macular degeneration. BMC Med Genet. 2008 Jun 09; 9:51.
- Photoreceptor protection after photodynamic therapy using dexamethasone in a rat model of choroidal neovascularization. Invest Ophthalmol Vis Sci. 2008 Nov; 49(11):5008-14.
- Increased choroidal neovascularization following laser induction in mice lacking lysyl oxidase-like 1. Invest Ophthalmol Vis Sci. 2008 Jun; 49(6):2599-605.
- DNA sequence variants in the LOXL1 gene are associated with pseudoexfoliation glaucoma in a U.S. clinic-based population with broad ethnic diversity. BMC Med Genet. 2008 Feb 06; 9:5.
- Characterization of azurocidin as a permeability factor in the retina: involvement in VEGF-induced and early diabetic blood-retinal barrier breakdown. Invest Ophthalmol Vis Sci. 2008 Feb; 49(2):726-31.
- Alleles in the HtrA serine peptidase 1 gene alter the risk of neovascular age-related macular degeneration. Ophthalmology. 2008 Jul; 115(7):1209-1215.e7.
- Endogenous endostatin inhibits choroidal neovascularization. FASEB J. 2007 Dec; 21(14):3809-18.
- Cigarette smoking, CFH, APOE, ELOVL4, and risk of neovascular age-related macular degeneration. Arch Ophthalmol. 2007 Jan; 125(1):49-54.
- Diagnostic and therapeutic challenges. Retina. 2006 Sep; 26(7):818-22.
- Melanocytoma of the optic nerve associated with sound-induced phosphenes. Arch Ophthalmol. 2006 Feb; 124(2):273-7.
- Effect of intravitreal injection of ranibizumab in combination with verteporfin PDT on normal primate retina and choroid. Invest Ophthalmol Vis Sci. 2006 Jan; 47(1):357-63.
- Successful treatment of Fusarium endophthalmitis with voriconazole and Aspergillus endophthalmitis with voriconazole plus caspofungin. Am J Ophthalmol. 2005 Sep; 140(3):552-4.
- Safety and efficacy of intravitreal injection of ranibizumab in combination with verteporfin PDT on experimental choroidal neovascularization in the monkey. Arch Ophthalmol. 2005 Apr; 123(4):509-16.
- Management of dislocated lens material. Semin Ophthalmol. 2002 Sep-Dec; 17(3-4):162-6.
- Mechanisms in proliferative vitreoretinopathy. Ophthalmol Clin North Am. 2002 Mar; 15(1):81-6.
Show More
Show Less
